1-9 of 9
Arne Brecht
Close
Sort by
Journal Articles

Amsa/ARA-C Followed By TBI 4 Gy or High Dose Chemotherapy Conditioning Regimens in Primary Refractory AML - Significantly Worse Outcomes in Younger Patients Conditioned with 4 Gy TBI

Rama Al Hamed, Myriam Labopin, Wolfgang Bethge, Arnold Ganser, Arne Brecht, Johanna Tischer, Nicolaus Kröger, Donald Bunjes, Hermann Einsele, Mareike Verbeek, Igor Wolfgang Blau, Martin Kaufmann, Eolia Brissot, Ali Bazarbachi, Christoph Schmid, Alexandros Spyridonidis, Arnon Nagler, Fabio Ciceri, Mohamad Mohty
Journal: Blood
Blood (2022) 140 (Supplement 1): 10455–10457.
https://doi.org/10.1182/blood-2022-170244
Published: 2022
Journal Articles

Results of a Prospective, Multicenter, Phase I/II Clinical Study in Pediatric and Adult Patients Using TCR Alpha/Beta and CD19 Depleted Haploidentical Hematopoietic Stem Cell Grafts Following Reduced-Intensity Conditioning

Peter Lang, MD, Rupert Handgretinger, MD PhD, Roland Meisel, MD, Stephan Mielke, MD, Dietger Niederwieser, MD, Paul G. Schlegel, MD, Johann Greil, MD, Ansgar Schulz, MD, Peter Bader, MD PhD, Arne Brecht, MD, Donald Bunjes, MD, Jurgen Kuball, MD, Michael Schumm, Dr. MD vet., Matthias K. Eyrich, MD, Vladan Vucinic, MD, Markus Wiesneth, MD, Halvard Bonig, MD MA, Kasper Westinga, BSc, Sandra Karitzky, PhD, Silke Holtkamp, Michaela Malchow, PhD, Christiane Siewert, PhD, Stefanie Biedermann, Wolfgang Bethge, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 604.
https://doi.org/10.1182/blood-2018-99-110124
Published: 2018
Journal Articles

The Impact of Cytogenetics on the Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Relapsed/Refractory Acute Myeloid Leukemia: A Survey from the Acute Leukemia Working Party (ALWP) of EBMT

Monica Poiani, Myriam Labopin, MD, Dietrich W. Beelen, Johanna Tischer, Jürgen Finke, MD, Arne Brecht, MD, Edouard Forcade, MD, Arnold Ganser, MD, Jakob R. Passweg, MDMS, Helene Labussiere-Wallet, MD, Ibrahim Yakoub-Agha, MD PhD, Kerstin Schäfer-Eckart, MD, Nicolaus Kroeger, MD, Bruno Lioure, MD, Annalisa Ruggeri, MD, Jordi Esteve, MD PhD, Arnon Nagler, MD, Mohamad Mohty, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4639.
https://doi.org/10.1182/blood-2018-99-113799
Published: 2018
Journal Articles

Life Expectancy in Long-Term Survivors Transplanted for Myelofibrosis: A Registry Study from the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation

Marie Robin, MD PhD, Diderik-Jan Eikema, Liesbeth C de Wreede, PhD, Wolschke Christine, Johannes Schetelig, MD, Maria Teresa Van Lint, MD, Dietrich W Beelen, MD PhD, Nina Simone Knelange, Arne Brecht, MD, Dietger W. Niederwieser, MD, Antonin Vitek, MDPhD, Lothar Kanz, MD, Renate Arnold, Jürgen Finke, MD, Liisa Volin, MD PhD, Ibrahim Yakoub-Agha, Arnon Nagler, MD, Hermann Einsele, Xavier Poire, Patrice Chevallier, MD, Ernst Holler, PhD, Per Ljungman, Stephen Robinson, MD PhD, Aleksandar Radujkovic, MD, Yves Chalandon, MD PhD, Kroger Nicolaus
Journal: Blood
Blood (2017) 130 (Supplement 1): 3307.
https://doi.org/10.1182/blood.V130.Suppl_1.3307.3307
Published: 2017
Journal Articles

Optimized EBMT Transplant-Specific Risk Score of Patients with Myelodysplastic Syndromes Following Allogeneic Stem Cell Transplantation

Nico Gagelmann, Matthias Stelljes, MD, Dietrich W Beelen, MD PhD, Dirk-Jan Eikema, Nina Simone Knelange, Ghulam Mufti, DM, FRCP, FRCPath, Dietger Niederwieser, MD, Henrik Sengeloev, Gerhard Ehninger, Arnon Nagler, MD, Ibrahim Yakoub-Agha, Ellen Meijer, Per Ljungman, Johan Maertens, Lothar Kanz, Lucia Lopez Corral, Arne Brecht, MD, Charles Craddock, Jürgen Finke, MD, Jan J Cornelissen, Paolo Bernasconi, Patrice Chevallier, MD, Jorge Sierra, Marie Robin, MD PhD, Nicolaus Kroeger, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3325.
https://doi.org/10.1182/blood.V130.Suppl_1.3325.3325
Published: 2017
Journal Articles

Comparison of Outcome after Allogeneic Stem Cell Transplantation in AML Patients in First or Second Complete Remission Following Either Fludarabin/Busulfan, Flamsa-TBI or Flamsa-Bu Conditioning

Thomas Heinicke, MD, Myriam Labopin, MD, Christoph Schmid, Didier Blaise, Arne Brecht, MD, Jean Yves Cahn, MD PhD, Yosr Hicheri, Anne Huynh, MD, Bruno Lioure, MD, Noel Milpied, Ghulam Mufti, DM, FRCP, FRCPath, Christof Scheid, MD, Gérard Socié, MDPhD, Bipin N. Savani, MD, Arnon Nagler, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3242.
https://doi.org/10.1182/blood.V130.Suppl_1.3242.3242
Published: 2017
Journal Articles

First Results of a Prospective Multicenter Phase I/II Clinical Trial in Adult Patients Using Tcralpha/Beta and CD19 Depleted Haploidentical Stem Cell Transplantation Following Reduced Intensity Conditioning

Wolfgang Bethge, MD, Stephan Mielke, MD, Dietger Niederwieser, MD, Roland Meisel, MD, Donald w. Bunjes, MD, Arne Brecht, MD, Jurgen Kuball, MD, Sandra Karitzky, PhD, Silke Holtkamp, Christiane Siewert, PhD, Stefanie Pflitsch, Michael Schumm, DVM, Matthias K. Eyrich, MD, Vladan Vucinic, Markus Wiesneth, MD, Kasper Westinga, Rupert Handgretinger, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 213.
https://doi.org/10.1182/blood.V130.Suppl_1.213.213
Published: 2017
Journal Articles

Remission Status at Transplantation and Treatment History Determine the Survival Chances of Patients after Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Lymphocytic Leukemia Who Had Received Pre-Treatment with Idelalisib: A Report from the EBMT Chronic Malignancies Working Party

Johannes Schetelig, MD, Patrice Chevallier, MD, Michel Van Gelder, MD PhD, Jennifer Hoek, Olivier Hermine, Ronjon Chakraverty, BMBS, PhD, Paul Browne, MD, Noel Milpied, Michele Malagola, MD, Gerard Socie, MD PhD, Julio Delgado, MD, Eric Deconinck, MD PhD, Gandhi Damaj, MD, Catherine Cordonnier, MD, Dietrich W Beelen, MD PhD, Stephanie Nguyen, MD PhD, Emmanouil Nikolousis, Arne Brecht, MD, Jiri Mayer, Prof, MD SCs, Mathilde Hunault, MD PhD, Jörg Thomas Bittenbring, MD, Catherine Thieblemont, MD PhD, Stéphane Leprêtre, MD, Liesbeth C de Wreede, PhD, Peter Dreger, MD, Nicolaus Kröger
Journal: Blood
Blood (2017) 130 (Supplement 1): 4576.
https://doi.org/10.1182/blood.V130.Suppl_1.4576.4576
Published: 2017
Journal Articles

Positron Emission Tomography (PET) Guided Therapy of Aggressive Lymphomas – a Randomized Controlled Trial Comparing Different Treatment Approaches Based on Interim PET Results (PETAL Trial)

Ulrich Duehrsen, Andreas Hüttmann, Stefan Müller, Bernd Hertenstein, MD, Jörg Kotzerke, Rolf Mesters, Christiane Franzius, Frank Kroschinsky, Matthias Weckesser, Anke Franzke, Frank Bengel, Jan Dürig, MD, Johannes Matschke, Thorsten Pöppel, Jan Rekowski, Claudia Ose, Marcus Brinkmann, Paul LaRosée, Martin Freesmeyer, Andreas Hertel, Heinz-Gert Hoeffkes, Dirk Behringer, Gabriele Prange-Krex, Stefan Wilop, MD, Thomas Krohn, Eva Fricke, Martin Griesshammer, MD, Aristoteles Giagounidis, MD PhD, Aruna Raghavachar, Georg Maschmeyer, MD, Ingo Brink, Arne Brecht, Uwe Haberkorn, Tobias Gaska, MD, Wolfram Klapper, MD, Dieter Hoelzer, MD, Karl-Heinz Jöckel, André Scherag, Andreas Bockisch
Journal: Blood
Blood (2014) 124 (21): 391.
https://doi.org/10.1182/blood.V124.21.391.391
Published: 2014